1 – 10 of 150
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Chronic active arthritis driven by macrophages without involvement of T cells : A Novel Experimental Model of Rheumatoid Arthritis
Hagert, Cecilia ; Sareila, Outi ; Kelkka, Tiina ; Nandakumar, Kutty Selva ; Collin, Mattias LU
;
Xu, Bingze
;
Guérard, Simon
;
Bäcklund, Johan
LU
;
Jalkanen, Sirpa
and
Holmdahl, Rikard
LU
(2018)
In Arthritis & Rheumatology
70(8).
Mark
- 2013
- Methotrexate remains a valuable option for remission induction of nonsevere antineutrophil cytoplasmic antibody-associated vasculitis: comment on the article by Faurschou et al Reply
- Meniscus Body Position, Size, and Shape in Persons With and Persons Without Radiographic Knee Osteoarthritis: Quantitative Analyses of Knee Magnetic Resonance Images From the Osteoarthritis Initiative
-
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis
Knevel, R. ; Krabben, A. ; Wilson, A. G. ; Brouwer, E. ; Leijsma, M. K. ; Lindqvist, Elisabet LU
;
de Rooy, D. P. C.
;
Daha, N. A.
;
van der Linden, M. P. M.
and
Tsonaka, S.
, et al.
(2013)
In Arthritis and Rheumatism
65(3).
p.582-589
Mark
- Headache in Systemic Lupus Erythematosus Results From a Prospective, International Inception Cohort Study
- Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
- Valgus Malalignment Is a Risk Factor for Lateral Knee Osteoarthritis Incidence and Progression Findings From the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative
-
Association of Genetic Variants in the IL4 and IL4R Genes With the Severity of Joint Damage in Rheumatoid Arthritis: A Study in Seven Cohorts
Krabben, A. ; Wilson, A. G. ; de Rooy, D. P. C. ; Zhernakova, A. ; Brouwer, E. ; Lindqvist, Elisabet LU
;
Saxne, T.
;
Stoeken, G.
;
van Nies, J. A. B.
and
Knevel, R.
, et al.
(2013)
In Arthritis and Rheumatism
65(12).
p.3051-3057
Mark
- Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
- 2012
- Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis